Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region.

Vince N, Li H, Ramsuran V, Naranbhai V, Duh FM, Fairfax BP, Saleh B, Knight JC, Anderson SK, Carrington M.

Am J Hum Genet. 2016 Dec 1;99(6):1353-1358. doi: 10.1016/j.ajhg.2016.09.023. Epub 2016 Nov 3.

2.

Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.

Chiu C, McCausland M, Sidney J, Duh FM, Rouphael N, Mehta A, Mulligan M, Carrington M, Wieland A, Sullivan NL, Weinberg A, Levin MJ, Pulendran B, Peters B, Sette A, Ahmed R.

PLoS Pathog. 2014 Mar 27;10(3):e1004008. doi: 10.1371/journal.ppat.1004008. eCollection 2014 Mar.

3.

Recombinant structures expand and contract inter and intragenic diversification at the KIR locus.

Pyo CW, Wang R, Vu Q, Cereb N, Yang SY, Duh FM, Wolinsky S, Martin MP, Carrington M, Geraghty DE.

BMC Genomics. 2013 Feb 8;14:89. doi: 10.1186/1471-2164-14-89.

4.

Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.

Tomescu C, Duh FM, Hoh R, Viviani A, Harvill K, Martin MP, Carrington M, Deeks SG, Montaner LJ.

AIDS. 2012 Sep 24;26(15):1869-78.

5.

Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.

Tomescu C, Duh FM, Lanier MA, Kapalko A, Mounzer KC, Martin MP, Carrington M, Metzger DS, Montaner LJ.

AIDS. 2010 Sep 10;24(14):2151-60. doi: 10.1097/QAD.0b013e32833dfc20.

6.

Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course.

Prada N, Davis B, Jean-Pierre P, La Roche M, Duh FM, Carrington M, Poles M, Mehandru S, Mohri H, Markowitz M.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):117-22. doi: 10.1097/QAI.0b013e3181869a9b.

7.
8.

Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.

Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML.

Cancer Lett. 2006 Mar 28;234(2):184-92.

PMID:
15885884
9.

Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.

Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER.

Cancer Res. 2004 Sep 15;64(18):6438-43.

10.

Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer.

Duh FM, Fivash M, Moody M, Li Lung M, Guo X, Stanbridge E, Dean M, Voevoda M, Hu LF, Kashuba V, Zabarovsky ER, Qian CN, Godbole S, Tean Teh B, Lerman MI.

Mol Cell Probes. 2004 Feb;18(1):39-44.

PMID:
15036368
11.

C to A single nucleotide polymorphism in intron 18 of the human MST1R (RON) gene that maps at 3p21.3.

Angeloni D, Duh FM, Moody M, Dean M, Zabarovsky ER, Sentchenko V, Braga E, Lerman MI.

Mol Cell Probes. 2003 Apr-Jun;17(2-3):55-7.

PMID:
12788025
12.

Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus.

Danilkovitch-Miagkova A, Duh FM, Kuzmin I, Angeloni D, Liu SL, Miller AD, Lerman MI.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4580-5. Epub 2003 Apr 3.

13.
14.

The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.

Kuzmin I, Gillespie JW, Protopopov A, Geil L, Dreijerink K, Yang Y, Vocke CD, Duh FM, Zabarovsky E, Minna JD, Rhim JS, Emmert-Buck MR, Linehan WM, Lerman MI.

Cancer Res. 2002 Jun 15;62(12):3498-502.

15.

Mechanism of cell entry and transformation by enzootic nasal tumor virus.

Dirks C, Duh FM, Rai SK, Lerman MI, Miller AD.

J Virol. 2002 Mar;76(5):2141-9.

16.

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.

Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7504-9. Epub 2001 Jun 5.

17.
18.

A G-to-A single nucleotide polymorphism in intron 2 of the human CACNA2D2 gene that maps at 3p21.3.

Angeloni D, Duh FM, Wei MF, Johnson BE, Lerman MI.

Mol Cell Probes. 2001 Apr;15(2):125-7. No abstract available.

PMID:
11292331
19.

A G-to-A single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene that maps at chromosome 3p21.3.

Angeloni D, Wei MH, Duh FM, Johnson BE, Lerman MI.

Mol Cell Probes. 2000 Feb;14(1):53-4. No abstract available.

PMID:
10722793
20.

Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion.

Kuzmin I, Geil L, Ge H, Bengtsson U, Duh FM, Stanbridge EJ, Lerman MI.

Oncogene. 1999 Oct 7;18(41):5672-9.

21.

Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.

Sekido Y, Ahmadian M, Wistuba II, Latif F, Bader S, Wei MH, Duh FM, Gazdar AF, Lerman MI, Minna JD.

Oncogene. 1998 Jun 18;16(24):3151-7.

22.

Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1.

Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, McBride J, Matsuo K, Ohyama H, Todd R, Nagata E, Terakado N, Sasaki A, Matsumura T, Lerman MI, Wong DT.

J Biol Chem. 1998 Mar 20;273(12):6704-9.

23.

Gene structure of the human MET proto-oncogene.

Duh FM, Scherer SW, Tsui LC, Lerman MI, Zbar B, Schmidt L.

Oncogene. 1997 Sep 25;15(13):1583-6.

24.

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.

Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B.

Nat Genet. 1997 May;16(1):68-73.

PMID:
9140397
25.

The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21.

Latif F, Duh FM, Bader S, Sekido Y, Li H, Geil L, Zbar B, Minna JD, Lerman MI.

Hum Genet. 1997 Mar;99(3):334-41.

PMID:
9050919
26.

Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene.

Renbaum P, Duh FM, Latif F, Zbar B, Lerman MI, Kuzmin I.

Hum Genet. 1996 Dec;98(6):666-71.

PMID:
8931697
27.

Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns.

Sekido Y, Bader S, Latif F, Chen JY, Duh FM, Wei MH, Albanesi JP, Lee CC, Lerman MI, Minna JD.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4120-5.

28.

Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG.

Wei MH, Latif F, Bader S, Kashuba V, Chen JY, Duh FM, Sekido Y, Lee CC, Geil L, Kuzmin I, Zabarovsky E, Klein G, Zbar B, Minna JD, Lerman MI.

Cancer Res. 1996 Apr 1;56(7):1487-92.

29.

Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.

Gnarra JR, Duan DR, Weng Y, Humphrey JS, Chen DY, Lee S, Pause A, Dudley CF, Latif F, Kuzmin I, Schmidt L, Duh FM, Stackhouse T, Chen F, Kishida T, Wei MH, Lerman MI, Zbar B, Klausner RD, Linehan WM.

Biochim Biophys Acta. 1996 Mar 18;1242(3):201-10. Review. No abstract available.

PMID:
8603073
30.

3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region.

Sithanandam G, Latif F, Duh FM, Bernal R, Smola U, Li H, Kuzmin I, Wixler V, Geil L, Shrestha S.

Mol Cell Biol. 1996 Mar;16(3):868-76. Erratum in: Mol Cell Biol 1996 Apr;16(4):1880.

31.

Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.

Chen F, Kishida T, Duh FM, Renbaum P, Orcutt ML, Schmidt L, Zbar B.

Cancer Res. 1995 Nov 1;55(21):4804-7.

32.

Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene.

Kuzmin I, Duh FM, Latif F, Geil L, Zbar B, Lerman MI.

Oncogene. 1995 Jun 1;10(11):2185-94.

PMID:
7784063
33.

Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis.

Kessler PM, Vasavada SP, Rackley RR, Stackhouse T, Duh FM, Latif F, Lerman MI, Zbar B, Williams BR.

Mol Med. 1995 May;1(4):457-66.

34.

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.

Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, et al.

Hum Mutat. 1995;5(1):66-75.

PMID:
7728151
35.

cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein.

Duh FM, Latif F, Weng Y, Geil L, Modi W, Stackhouse T, Matsumura F, Duan DR, Linehan WM, Lerman MI, et al.

DNA Cell Biol. 1994 Aug;13(8):821-7.

PMID:
8068206
36.

One-megabase yeast artificial chromosome and 400-kilobase cosmid-phage contigs containing the von Hippel-Lindau tumor suppressor and Ca(2+)-transporting adenosine triphosphatase isoform 2 genes.

Kuzmin I, Stackhouse T, Latif F, Duh FM, Geil L, Gnarra J, Yao M, Orcutt ML, Li H, Tory K, et al.

Cancer Res. 1994 May 1;54(9):2486-91.

37.

Mutations of the VHL tumour suppressor gene in renal carcinoma.

Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, et al.

Nat Genet. 1994 May;7(1):85-90.

PMID:
7915601
38.

von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis.

Yao M, Latif F, Orcutt ML, Kuzmin I, Stackhouse T, Zhou FW, Tory K, Duh FM, Richards F, Maher E, et al.

Hum Genet. 1993 Dec;92(6):605-14.

PMID:
8262521
39.

Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435.

Li H, Schmidt L, Duh FM, Wei MH, Latif F, Stackhouse T, Lerman MI, Zbar B, Tory K.

Hum Mol Genet. 1993 Aug;2(8):1326. No abstract available.

PMID:
8401520
40.

Identification of the von Hippel-Lindau disease tumor suppressor gene.

Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al.

Science. 1993 May 28;260(5112):1317-20.

PMID:
8493574
41.

A centromeric microsatellite probe on chromosome 3: LIB 9-95ca (D3S1338).

Schmidt L, Li H, Duh FM, Wei MH, Lerman MI, Zbar B, Tory K.

Hum Mol Genet. 1993 Mar;2(3):335. No abstract available.

PMID:
8499930
42.

von Hippel-Lindau syndrome: cloning and identification of the plasma membrane Ca(++)-transporting ATPase isoform 2 gene that resides in the von Hippel-Lindau gene region.

Latif F, Duh FM, Gnarra J, Tory K, Kuzmin I, Yao M, Stackhouse T, Modi W, Geil L, Schmidt L, et al.

Cancer Res. 1993 Feb 15;53(4):861-7.

43.

Molecular and genetic characterization and physical mapping of 11 new markers detecting multiallele restriction fragment length polymorphisms on the short arm of human chromosome 3.

Latif F, Modi WS, Duh FM, Schmidt L, Li H, Geil L, Orcutt ML, Heppell-Parton A, Rabbitts PH, Linehan WM, et al.

Hum Genet. 1992 Sep-Oct;90(1-2):17-22.

PMID:
1358787
44.

A microsatellite polymorphic probe on chromosome 3p: lambda LIB12-2CATT (D3S1244).

Li H, Kalman T, Duh FM, Schmidt L, Wei MH, Lerman MI, Zbar B.

Hum Mol Genet. 1992 Sep;1(6):452. No abstract available.

PMID:
1301919
45.

Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies.

Sithanandam G, Kolch W, Duh FM, Rapp UR.

Oncogene. 1990 Dec;5(12):1775-80. Review.

PMID:
2284096

Supplemental Content

Support Center